Kuros Biosciences Ltd CSBTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CSBTF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $14.81
- Day Range
- $13.99–13.99
- 52-Week Range
- $1.89–14.81
- Bid/Ask
- $12.81 / $15.09
- Market Cap
- $516.30 Mil
- Volume/Avg
- 235 / 1,525
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 13.71
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 80
- Website
- https://www.kurosbio.com
Comparables
Valuation
|
Metric
|
CSBTF
|
MOVE
|
VBSN
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 47.46 | 20.97 |
Price/Book Value | 7.62 | 8.14 | 2.12 |
Price/Sales | 13.71 | 5.04 | 2.17 |
Price/Cash Flow | — | 22.25 | 16.14 |
Price/Earnings
CSBTF
MOVE
VBSN
Financial Strength
|
Metric
|
CSBTF
|
MOVE
|
VBSN
|
|---|---|---|---|
Quick Ratio | 1.63 | 0.82 | 3.89 |
Current Ratio | 2.06 | 2.33 | 4.42 |
Interest Coverage | −72.91 | 9.58 | 887.05 |
Quick Ratio
CSBTF
MOVE
VBSN
Profitability
|
Metric
|
CSBTF
|
MOVE
|
VBSN
|
|---|---|---|---|
Return on Assets (Normalized) | −13.07% | 8.23% | 8.59% |
Return on Equity (Normalized) | −16.04% | 17.55% | 10.63% |
Return on Invested Capital (Normalized) | −15.77% | 13.31% | 9.97% |
Return on Assets
CSBTF
MOVE
VBSN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Nqdfrrlk | Pstkypd | $183.1 Bil | |||
| Stryker Corp
SYK
| Wsyzqxmyf | Znkql | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Fzbdyskj | Hclmgr | $110.1 Bil | |||
| Medtronic PLC
MDT
| Jrrrjxf | Ffpplw | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Mhpcmkldtz | Vcfnq | $37.6 Bil | |||
| DexCom Inc
DXCM
| Xwxprxhkhc | Ybpx | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Bzxylsw | Dmpxkst | $24.1 Bil | |||
| Steris PLC
STE
| Qxhhqnqh | Fpkhgjf | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Mqhgvxvsx | Xjjp | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Tszqrspx | Jkfxz | $16.6 Bil |